From belh@pacbell.net  Sat Jun 23 22:41:48 2007
Return-Path: <belh@pacbell.net>
Received: from plg2.math.uwaterloo.ca (plg2.math.uwaterloo.ca [129.97.186.80])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l5O2fmL9026573
	for <theorize@flax9.uwaterloo.ca>; Sat, 23 Jun 2007 22:41:48 -0400
Received: from dsl-189-144-119-194.prod-infinitum.com.mx (dsl-189-144-119-194.prod-infinitum.com.mx [189.144.119.194] (may be forged))
	by plg2.math.uwaterloo.ca (8.13.8/8.13.8) with SMTP id l5O2fcaX003604
	for <theorize@plg.uwaterloo.ca>; Sat, 23 Jun 2007 22:41:40 -0400 (EDT)
Received: from dccz ([112.228.123.155]) by dsl-189-144-119-194.prod-infinitum.com.mx with Microsoft SMTPSVC(6.0.3790.0); Sat, 23 Jun 2007 21:41:27 -0500
Message-ID: <000901c7b609$29cc6350$9b7be470@dccz>
From: "Hugh Ballard" <belh@pacbell.net>
To: <theorize@plg.uwaterloo.ca>
Subject: Researchers have been looking into this, but - as for most areas in aging research - there is comparatively little funding for these sorts of studies.
Date: Sat, 23 Jun 2007 21:41:27 -0500
MIME-Version: 1.0
Content-Type: multipart/related;
	type="multipart/alternative";
	boundary="----=_NextPart_000_0005_01C7B5DF.40E7B550"
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 5.50.4133.2499
X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2499
X-Miltered: at mailchk-m02 with ID 467DD9E2.001 by Joe's j-chkmail (http://j-chkmail.ensmp.fr)!
X-Virus-Scanned: ClamAV version 0.90.3, clamav-milter version 0.90.3 on localhost
X-Virus-Status: Clean
X-UUID: 469b51cf-93cd-43cb-ac0f-54cee6796fba

------=_NextPart_000_0005_01C7B5DF.40E7B550
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_0006_01C7B5DF.40EB5ED0"

------=_NextPart_001_0006_01C7B5DF.40EB5ED0
Content-Type: text/plain;
	charset="windows-1252"
Content-Transfer-Encoding: quoted-printable


That is the question that scientists are currently attempting to answer; =
there are a number of good theories on the go. " This article serves as =
a reminder of the dangers posed to the future of medical research, =
healthy and longevity by people like Leon Kass. If the latter, however, =
telomere research might yield untold dividends. As I've been saying for =
a while, the scientific side of progress towards a cure for aging and =
age-related degenerative diseases is sure-footed.
Investors are scared away by political threats to fundamental =
technologies like therapeutic cloning.
" Given the cancer link, telomere research is important in any case. =
htmlThe in-house health media at the AARP are starting to show an =
interest in healthy life extension, as well they might. "But while they =
may not be investing in the companies themselves, venture capitalists =
haven't completely abandoned stem-cell work.
Is Demography Destiny? Transhumanist groups have long played an =
important part in the healthy life extension community. We should all be =
thinking about such things, but this piece only covers half of the =
topic.
It is one of the great accomplishments of the past century.
Here is one other thing to bear in mind: rather than chasing supplements =
that may add a few healthy years to our lives, shouldn't we be calling =
for faster progress towards a cure for aging?
phpWhile meandering the web, as I often do on Sundays, I came across a =
promising article from Harry Moody, one of the many bioethics-oriented =
folks affiliated with the International Longevity Center. UN Ban On =
Therapeutic Cloning Likely?
" Biogerontologist Aubrey de Grey makes the case that "eventually" can - =
with public support and better funding - be within twenty years.
------=_NextPart_001_0006_01C7B5DF.40EB5ED0
Content-Type: text/html;
	charset="windows-1252"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">
<META content=3D"MSHTML 5.50.4133.2499" name=3DGENERATOR>
<STYLE></STYLE>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV><FONT face=3DArial size=3D2><IMG alt=3D"gradation" hspace=3D0=20
src=3D"cid:000401c7b609$29ba13d0$9b7be470@dccz" align=3Dbaseline=20
border=3D0></FONT></DIV>
<DIV><FONT face=3DArial size=3D2>That is the question that scientists =
are currently=20
attempting to answer; there are a number of good theories on the go. " =
This article=20
serves as a reminder of the dangers posed to the future of medical =
research, healthy=20
and longevity by people like Leon Kass. If the latter, however, telomere =
research=20
might yield untold dividends. As I've been saying for a while, the =
scientific side=20
of progress towards a cure for aging and age-related degenerative =
diseases is=20
sure-footed.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>Investors are scared away by political =
threats to=20
fundamental technologies like therapeutic cloning.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>" Given the cancer link, telomere =
research is=20
important in any case. htmlThe in-house health media at the AARP are =
starting to=20
show an interest in healthy life extension, as well they might. "But =
while they may=20
not be investing in the companies themselves, venture capitalists =
haven't completely=20
abandoned stem-cell work.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>Is Demography Destiny? Transhumanist =
groups have=20
long played an important part in the healthy life extension community. =
We should all=20
be thinking about such things, but this piece only covers half of the=20
topic.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>It is one of the great accomplishments =
of the past=20
century.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>Here is one other thing to bear in =
mind: rather=20
than chasing supplements that may add a few healthy years to our lives, =
shouldn't we=20
be calling for faster progress towards a cure for aging?</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>phpWhile meandering the web, as I often =
do on=20
Sundays, I came across a promising article from Harry Moody, one of the =
many=20
bioethics-oriented folks affiliated with the International Longevity =
Center. UN Ban=20
On Therapeutic Cloning Likely?</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>" Biogerontologist Aubrey de Grey makes =
the case=20
that "eventually" can - with public support and better funding - be =
within twenty=20
years.</FONT></DIV></BODY></HTML>

------=_NextPart_001_0006_01C7B5DF.40EB5ED0--

------=_NextPart_000_0005_01C7B5DF.40E7B550
Content-Type: image/gif;
	name="insinuation.gif"
Content-Transfer-Encoding: base64
Content-ID: <000401c7b609$29ba13d0$9b7be470@dccz>

R0lGODdh7gGdAPYAAP///+JrNyZqa4Qwd5qBr9J3JaNpfBKafT5ManlFiF5zcVkcTLpbmSRQxSNM
uYkJRNg+ikelkFeOmFR7g308N2JmPIlbvAdliHhyKEoiXKxcozA7Rx1FVElXYDtqoFs1KYMqPSs9
GKwvnsV6Xp0SyaCXp4yNNHAwdEYTbC2je2vDoVNNwMB6Y4yTkoRGMTKaf4wjTDhKkWogprY/M59D
m2xHWMVjTVYbi8U2QYwoWLFwoWUuinNooEY9H55UvYQXk5gZhrcXdbgsqIIviEWidyhHkMVIpCwg
ToVMVEMRnQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACwA
AAAA7gGdAAAH/4AAgoOEhYaHiImKi4yNjo+QkZKTlJWWl5iZmpucnZ6foKGio6SlpqeoqaqrrK2u
r7CxsrO0tba3uLm6u7y9vr/AwcLDxMXGx8jJysvMzc7P0NHS06w01IYVqjQv193e34wEpAKDQR8Z
CS2DGuxAGZZGK4VB6oXkmRlGAQWMPAeFKiZo4tFBUw5wCBP6EiBAgQIAIDLs4FEPgAYdNE4MOaTg
yKACGAZRIGRBHiEDKkINsAGy4CJuhCSc0NRR0w5DIBTqTNVChwZxAE7QaAETgAceCI4MIDTBRKOh
mIoKQgBg5aCmLgqVpCEwUYUXHSYkINSiItBEST+6BLBWkDWAhf/AGiqrI5KNq04BTNBgxNDDQjMT
qfupiAdSpYPCmsgqyIiRkot2fF1bY6dlUmVp+NwoguiBfwAIHsnAgJACfoxapIT0FsA7AKAHjWZQ
gF/DAhu6AohnwZ8ibn/JEtIwJIMIRLMBFKhw7xAPQ6sHNSxUtoVmAMU7L0ItiN8EHo77EgpiKEYh
GyfGArC+OVEHl6UBMD+9obHjFRbK0Ss05MV0QYFdJqAnFQVl0SCgBWeaCRRQpQhKKkggiAw0NAcA
EjvsUJYgGgyyEWyFZLAUACEpwCACzwlSUoqKNKSAAWQVmNEQGkhoyDt3lTgVi4JIJYiNplE3SF0a
1fhZItwBMBL/i/mNZ4gMhWC4ITsAJnLEaFaxZSIhjjUpSAJBQEhIa4PcNOCZm/hU1yAVXTCVUncN
kpduiNRT2Q5DtFDBXxgatiEAawLwVmyCjCinC2F1OIgFExCKiAIJ4IAEm4n4WKhyBRQ0p6IIGlJZ
IepR6paBghyJSJIFcWrSIGQK8mGZFA3GSFJw1ibIYm2V5GUQQ0UoXCE8oilsJZu99sJnBzQgyGhG
JGlDBnstokJAB72aYoDrcSiqo+INEuduhrxA3iLkBfbnIK+BaIh42QDwbbc9GnLQPEK6CsBxpTpK
SLuuCdStD/WeRMgJMUiwYaBWFsKvXpwK0qgg9ExLJ50/Dmvx/yVFwvaZB+gaciJ48AIU4Qk7rNAq
AGZqK+ggNnJMyLeCNAjyOi+8AKYiCgwgqZkFumqkvu4K4tJIjYFqSMqD4FAIOxjNxKmph3RgYoP2
ldQwANGJKkjKHSKMSLpCA/CxeFbXLAiMVQ6yp85aX+x2IwirA5oHXRk6CGNFI5J1Okk7PByAQhEl
iMsfGcIDX0wdoMC4iUSK4ZCHeHZqIWuFzHiZhkxaSNOCtOkmIljlukKwWPvFFF0dnmyI3XoBgOjh
g4z+cOcR1oA0AI63/fbuiBBnnOCxpUXbcveAfTUhWRugwAdBBIGawZmd1dmxp2A7SZKtq1yOIa8+
UpQDDoTyAf911p0lCrWp8a5+IhnQaCOhOIKEQFcOqpgIkABImIMBSrPJDmHP8NL6BkhAZqiugAhM
oAI5cbsFOvCBEHQE2CJIwQpa8IIYzKAGN8jBDnrwgyAMoQhHSMISmvCEKEyhClfIwha68IUwjKEM
Z0jDGtrwhjjMoQ53yMMe+lAnVxpCyH5IxBl24AgnMAIDYKYQHx0xiZOAyiBCVcQqSsIjaruE8j61
iBB4bRI8MJsmIkCoI2aABkawgQ0qIDWYGUED+OGRagRmxTpC4ghoLIQLEIA/Q1jDVxBTQQVgcMBB
hCAEEgDaICBQAA4o4jNUvISjsNidRk6ABXscxGNWoIHY0GD/WkASpB1H2QglrlEQiNpLtxgVG9VI
QAGBUR4FBoA2RBwyXwd4AVLqt0Q29qwQCnolyQqhPAUdgnqEQCK81qIbgM1FEAoiGimn6RWpAYCL
ZAvjBEY0LUGYBwAKqMH+jFmIEBDiMxI44mgEsUap5QURdpsAwXZQy2Iq4JfnPAQaTwnOQbAojlKR
GLbmRc2C5k0QIwBA/daxvdIpbBDkJIQ5ERSBMd2KAxIYgTQPcTkuRqeW+OwUIkyA0YzKrFucRCbW
aleyQdTSoNTs5YtmkL2V1XRcfVRSmJDAxUNY6AV0Ytcg6pOIywUoOJob2CH0BS8DGGAGuWmYAAWR
tVe9FKbT/2SjAjQHMhqYpJV+M4QBeLoIBYQEAClIJ5eEttUaUCxgKBsEF7lYjx4sdV3t3CpZd9Mt
0iXvbEnFqmD5uqoDDCBMq7FeJDrAgQNUlJJBYycF2iLWbm5tEAS9Z1mAMtFCONYQqYxT5UxyrMOi
DX/1COlgV9s81UqCAzCBLBMX4UoPNVQQJTiXYBhBJ2XBZnH72e1qh5uQIxL3uBaELHKXK4mrNSqi
hKgBCSqSW9cy97rN6Kog/LHNyxWiBkOwwIaqQ4PuYfe82eVLPOJ1tkS86iEVGR9658uMDsHrH+TJ
WuTumS0SAKCz9A2wMRzj1asAgDzWbQF/1bERAAv4wcNYyv9rKhIo84XGpcoZxFkhzOFfeGAIEeHZ
/1rTRwVs4Ix3wZAAGNThFvdCBjn4QBIIIYQWNMxSSIwPAIqgAJq6+Me7mCCQh0zkIhv5yEhOspKX
zOQmO/nJUI6ylKdM5Spb+cpYzrKWt8zlLnv5y2AOs5jHTOYh96+ghKuFcnUiZA+kWTkb7mBPCRHY
LyInFRlR7Cf4pow3z2LNv1jBBJ4rKFfOuRGKpVshTEDZ41FQz350BKRBkYAdCMWzn1DwMki3DOge
wsKRoJgPPjMBIKxnWrBExA4IRwNQF2KhYdWkTmo0CD9fooHg/CaHDJMEISOifrCmFyVmfAhbZ2Jh
X3NfJj7/c1iqygRp+9M0hxxtmtG0agI2wGY8VnWIHVAImAVbBw96XbHBCeKMmJi0rrdbCRQ5ZnX5
ZUS4d+2zQ6z5rToRnLldkyVL7CAdClIAnXiQIRRMut/BYZLsWEWJHRj8ZHRDQLpsYE1HRCiSOYlR
oB6ub6NMINi8VRyv1CGBBJAsVENxiLgXIfGVJMkAe3xOl0aniH9LG5wCnxLBDc5eoxQKZjBCESQm
TTFcuxnfg0CReg0xrosTXedmkmKIxMqlIYLK5P+OxLEU+WrYoWLr7EaiAfZR06J5lSuKyFM47YY/
XIs1ABBlqKBMNrtTq8DTP2rBWThuuKQEZjkT2Grr3n0I/1QTjBBs1zsAA0eIo/h90ncdREqCU5Gr
/sThiqBkkngaLSMUeBFq52JwxHGWQflzEHAfBOcRx6q6UxWW6y6EwQigKL6XyvGA9tsQgQCEpsPe
vCwDAOkBgIJBWIpUdOZSq3pfkRMQTO29IwDme4SsNI89SW5dusMOgHRN/CNBrqEBS0JCP/vEkes2
BcBLC0RsRnCHO+KJo8gkQNA62ZhTpuZIITAwvwKMD2TrBR2DACUYpjUsogOJ5E8dcUaFtFTNhlmS
xyYO0S6KknvnpmGV9AHuJgjylwgUogI9kFnAAjnq0k/dQQgaeFC9wWySR3/eJhj3tyxAgICg4QA8
sICJAP+A8+BdoxI5FqEBz0FJQHMy8hU7iIdYq5Ehg2BXhwCESXAE+YcsNvgy8pN0shYazMaDm/AP
buYaVcESFKd+7LYbupI+nfMrglB8jfAteLNKrqdfguETLEJtEyQ1MEcVrMdtweeDWnM7pjIBGSAi
ahR3jDByibUCAAdRDvEXOwd5huISLtCGidM4DAdNDJUy9RAbE0cIIMdKi7OHuCNcgxAgcwOIIqII
MzcmrREqIVUP1yJS52EIsMZtjGMjK7AqGWc4crcxivYRFJdwhvBcvBIKoBGEYug3k6JKAAAwrFRW
hCgI5iMUQ3F8WSQI2Ud4V5F/DkVbtKcBmHhnTGFgVhf/JGf4jMI3CGroGaZSPwGQeibYCKgGADEA
febojbZ3CLXUFTVwjX2BH43SfQpWA7QEUYrXIRwHEweAe9UYa4lTaoxDeYlgYa1RjAWYCMyYCM93
c4UAFFEHi4TgjgZGEk5iidjxKqyDOeUYPKgHeMGhKqXikNZlCQmyTuPHRwCggTIXgLBxkihYj5tD
g4qwUDqIhYZVi41QEe2XU+eWRs9jAzgJLoqQAzGwAzRQUfXohK+RSFDDLCzBHbPFdIRwEGbyASJ4
eqBoCN+CPzq4guh3k9FGFlQiCCIAlNuFg1NBCJwWG7VEUFbZhJsjUguYRolwH71Rc1WZCFcTKECD
PReG/5d0BADzQgOtcVWDkJSlYoM1cYLspEmEWSoRCAqEc4rKUXGhYV/5oQHHcjOJkIt45wh4l5qX
Y3ImowgEQAM7Z3yJwAK2gkpCB5WKYDI9Y0y3qQgDoJuS8ElOl35S5BB6F1e4aQtt+TeGcABg8kmj
CJyeZpvTByShWZyoaDWX0CpKqXXIk5zrUREhZXA1UhQeYGKEkCkvgjdkuCrVaVmfQDgnQJnaIw//
qI2jUAD/EQl4Yl0akAA8dwnOxAuGV44kqVnWoIaeCZ2YAATaQQihpwgGGhjsKQlThQt3B3mHEDjU
SAgNsVeJ0BlwiBAY0H0CFp0qhC9l9gwPgWyqUAG5SP+SBaQoLpoMUhcJEDpkD9Ga+/YJswRXo5Ci
PMkLmSgJCSoLNrAAlDUXKdoIvoaWy4EJyEajqZAN+okKkCakqgBfjcBphVEzSUpMpRBGL3BYc4Rv
XRoNevgKmGST0oIzCrAnhgCiu0EbIBcJMABMr/CnBaJ3JLAAlDaMo/goj7QxijCnEhAel5ANMTkJ
sCmZcnUCejiortZ4HWGBx0SdvNJNh3YLG3Kni5CQhaBEjEkIKbWjoyCfi4A/sqSImiUIPXBIDSgI
OoYI+cF9jEBLKpctrrAUCmIdJ3Cr7oFEjeAD+FEOvVImCaA8i3CrE1V9ZOo6ieIYTcoICjBLb5qD
bbH/RgLwpq00R0Hxby9VrK0iOdv1ROOoCGSSHtHqUmDaCDAXpZERrcGxiMwpUWSCqprUS/eQKCTx
j6lwRvCSbd/RCHQSTvuDowDzAYfkRYuQRmzkT9iopg+YCPbUOT4wBEUIAGSEflr1Lm80hp9JdQqS
oBM1solhbeJRENm2NAAFMaoRHUOwRaZRIBJ7SyWIr6kaLmtKVWgqTsW0WJBVsqMKAD6yGvMoreaI
HYUwsqBROZJQIDHgVOEETcYEsj77NfsETQqbIlfDkznrsFz7FxVxSDrQl43ZGHl1Td+RsauAR0bA
SHfDR+8aXftCSKk1CP7VWeO5SJbEmY+RLz0oitBI/wI9+yPVlwgccEmZFB6QARpN9wj+JQjmpJUA
S0kQ4DCOCiRWcyShCkgHFjkF4mCx4akHlS/V6VBmkhJ/iqOPAFmOdJeHEEkSUjJBIEpRG7Ia07mL
JAlZsyqz+44AwLgTC69320gA4KhkE6FayDhvEazlFKG0y0iRywIKdYUl6KULWXaLcFTe+hclkKid
NaLhy6rYy62F0BoTtXW55B7iaATM2qtyWW6IRq3mJL+xNReMEZcA4I+Kcy/P2KWpi2nLwgghA1Y2
YiYPYSiTChiEwEyI4F0PkTIb1TNMSH2f8b+biUoWRwihIsEDg6wVmxjYqowDHKEw+phoo1uG1L4L
xf+G4tu+p9AabXGt5SFXhBhf/+WRiAC0TcKigGqhMxy8BzC4wOh58icQEXPDidCz1YosNpIu7fJO
WjEIS3Gz8hS1baO6HbMI1xaBAjGVMFIZIHWc5Pi2wqYXX0xPaKs7ABYbV7yQSyuAFbnGEvW1iNAt
D4FN9gNUXax/JCnDmtu+SetOlfFPV8GmqNAt+LO3hbAq+3O0whrEh/QCBRCd46kokYQz1SEIRVit
YDwICVU03cINYAIjtfMIExUC3BAbf4FGLEBSMdM7sOlstqM2l7yRfczJgtCXuQoAUxUqKWE78iBI
B8HHkAAvqeybxARK+yh5FfCwdHxOnxEBtTwIt9v/vY2APx+lO5qrvtyLUAo1lKiJXyhxCNestZ2D
T7IMNQCgXCZlH5s0Hu18CjL1UpSMxC7FU6olABWAAdF5VV7FKBADCdVlq9KRL0DVpwDgY+CS0LOz
H68ECZ1V0B/8cYPQS0OVCNynhfocWOknCAQdZ4+gh60FSPMITkSTVBNMCLtK0ePoSvV6qhGdCQGn
emF8SAStCN/iY9r3kgcWUhSwU41QAaDxccqKip/3CloVtLBg0h14CZ0VHGkFtNZ4hSuoNXoqURWM
VmqVCEZMCcBXCR16s7YlCPWXQEDdmvySx7oxpW/9CGYUo1z2rXrdCCQNDiwsxQs005WAdseQ05nA
/11neglcPQuN/caKoJGHEBLf/BSPwNeXoAAzg8OSkNbToF9z7AgY4BLGVRV+ESy+gTy0wMPrOwql
9deJIEAhUNkhXQhnDa+R4BTfvAFBFJKaoGCIvC9soQgb1cKOQNiSwNr5EwnA6wodigl+hVoV8ANS
VxbPLQgVcLu8HcJ4uas4PLircNu/8MIhYCEPYgnITdnndiUnQBvt5ddTKoHxDLnyoQhEZYSuKV2E
7UgvADaZohuq1C0F3MaO0MGq0DMvnAkaQGjO1tPlWF0iAGkcwAEVkAFXgoqmEwllEeGaYAI18BDY
6AjgNRflRaJmdd8+1RBabNsbuzXzyiaSfcTJtP9mHq7Zlfi9mVAfLpG0t/LhKTKRrRTfDGpTE9sc
jmTewLTZK0gnAhVd4eVa5W1WQiMAB3Dh7jIfeaFdDsM6J8fX5YXCyEGTWore/MEJS24oKYEtlZEf
f+vQh3DkHoEjWjpE8aRY4oWeX+5glDBZh3MfPVIUoIQyKRNe1GEBXisIHGAijKUIg2YDkwVPYVII
NtcuZVGr2AG8K17Pa8bnLtlzkbMwlo4IjrTjR2BenN6PxhdQztjWh5TomZ6D2qexteiCg94Irr7o
HQAaWJRU0jRE3pUhfBbPwWHojWslpW4DSBAWQuN1xsy0AUV/iaBZ9UDFhMAB7yEbQ4Dsi/Acx4f/
NBuhDmortXoeNlUutcl+CL4elrdz5/zV7ImMCUQVf6USHE7nAMGVyQxarSYw5oRgAouxAeDNdApm
LqKyAA6mpYqF4hx4yhCFLdWRuYhGG/d936jOtTFBW4RgqEGM3Y9wNUXBOAlgcvYOuI0QG/xtCBPv
vbclCOFDPvd0vsmbxOCIGk4B8Nq3zp+INSV3Ai0/F6P8XxNr8l8BGu2NGyx6LDlPCD0f8+rwt4Y6
7vX90Qw5CNt6ukofMDAP8VAfCX8RvZdCtM5JBLrz3CawAbQNTGrk448QrUQw4vgu84Kg8IkLxl6y
2FIrKp7tFf8RHNZQ9/FEW/UwBEzYWXI/mAp8/4zy1OWDsKkyXhD60hx8T3Uk7POW/ipb74VRfxeR
j4ULjTXylHV8KPPB0QFUDhqt0ZrddVVUdBb1kB92BfUWEicRFaeqHzCBD/eV4DImkS4V8SFAQctR
EgNm9SkE1qyIUAH7mAAeoL5T+7j1nAEGwBIYaFFPYgjL7wGrgg4/nwjW502O4G0r0AAx0C6EI2Hp
sP3IpwgFEFj1U8y1tgIDoPEVoSgaMQQEQEbVVqX2kdA4jt01QEWAMAAwSKhBOBhxoEioQGgzGKOA
UYNwaAmwM9gwWAPgQSgIkHA5RBhxOWhgiUFoNLhCKDAoQ1iBStiSq2E4OESQeMB4lEGIFDl5y/9z
CAtge7lwyWtqqTBs8AgQQ1h524360juYOShNDCAxGDy4cSlgQtFqZGHhDTA0xPOCXn+o6PE5iIaN
AofgHaJ3iZklCR5KEeKhqx7AQdhk8XvVwEEHQuAGgRgEscWui/WUDUJIcggIcy0KFdIg4YU6kgCM
yENJ86I/QhsyCCQ46F0Hk7fGOQinr+FHAEQJZRgCs+MlG0iQjDNY82S+A6MAKHR2S5e0nO6wkgR7
yJw3qU4F5nzrTQihE4M6zoSLN++lI5Y26SUk11tLQkAb/T2MODFeV4pJnmAANLEHGTlwoRLRgu2l
HTuKDOI7iDGACQcUBNFUi1/gxqxbu34NO3b/WJFjZdu+nbg27t28e/v+DZz1xN20gxs/jvO48uXM
mx9qQeME3cyLXFeocEACw0MQLw52jioyeMWVdd4FANo3jcx5jfhQOD64i/ivoVneNcTnL0UHhl9c
YQEP6gTRggoq1CLAC//Al8ty9h2GhHIbwfZgPdU59RsN+y2mAYC3TZgYWhgq1olsNDCnFgCGjCVB
CoR4YNh/K+TzwigGGCjBhBZdEpJu1LBzSAcKmDBfNwkEcWM9KaICUwrnWSJkkTUZAV9rLh4C5GtL
duMPjIOEYgkCPPh4yIEdgDVBQ5YUR85fohFyWmJX8tSYiOJYQmZeM77A1oHNvKhSPbXBmCVB/0Ja
YtMKVeZ1wyEnRkdXOmnRBN9pfv4JwAsVKJBAV4MMdqI3GaQHQAcTEMkNKqaJYGAtFWhmiQ4ahrqe
TE8ecio3NlmwQqi3XKfpITd05815pHrTa5/1DNugNxdc4AEP5gxUAIgITKCBTd5IkMB1tmyaQA4P
tiArAY9StxivvgIggmLG1nnRujldewkNMplGyD7OcCpuo4OU6yt1wUQ7aijVnirlrr0m5qmKg2Qg
wi8A3HWsNwHedakzAijAQxBxfsqmqIcIMAE23QBBiJ/XCbCxUw3vogEQxBBAyK2ETHCIaE1ZsnLL
DyeQy3eoKOKASRkYEUBkj0xAFIACSnXpIP8bdzwI0BF148BRhyRdAcmDMG3Tm5dMUJ4sMar1Hcr7
2WyJDTXgHJrTzxkINwAsnw1As7cQbTTSSid0sTd3EwW0JTJHXHPRIKLCNI9w3tyMRR1/kEFXtMVs
Cn9MtTJI15zEs6heTelwiASaj0gSn0cOooIEJ+ywLypiyVoPmEFRkCoqH+vLCCE7NCVNKft44o0J
OXPUDVgxjuMwl/8YNsBAGEyI+5iMKeRp1BtzuhRReXriX2TGM5WtPN5E2vudbQ4SKduXVC/NojhG
ejen4vTovJcARF/A9IOYBQBe0UhwCuAeSIQGgBNAZR/9gVHF8HQJqahiZIRIwEp+Rw4NkK7/H4eI
ETYWd5AZKUZoJ0LfxC5AiCPYjiRBWM85EvA6yF1CaCZEhclwlSdfdQUsDRMazQKSqRd5Q0oBrFny
KvgQl3QDhYcwGdxMFRogDmJ3QSJEib7zw2TsLDJFit/5LOEp781FUiQxVbYIIS8ARC1TpkoADg64
PlQw0REyTAgN6tYNEJUob5aoIbR2dguxTcwytZDKGz9FCHOZ8C6pAgoex+Y+mgitFJix1QEUN4zU
WKhMo+lFRzpmA+lYblLeEE8BNgC2bhRIBRN4QF0eR8g4toQ/RfMGKq93MVghb4qx3OAttEaY9D1y
c7z8WgfHyMc4oqIDHRgGAzpHpylRKTmW/9DGIYIQysL9SwP5adcgL4JKHmgLJJdY49SwiUh+AHMQ
kYkRjw6gy2OyL5aD8CZ3mskPQULtEGzJpt4eZk+KZQAyhUGF0+CZGNrIKlKmW4QDUwTCbxzpRgdC
X8sMgAOr7GAwY3FIN8RTvWd6o3UxtFsBMfocR+UrHc8ric74REAFoBRku/AlKsJHiPEBUnVImssO
ZHCi5aUTAGm8RAaiNwhrtYJX9aCFJayCwOh4NJLb4NwrF0KNYgzVGzgNSj1W1w2hKrN5Rl3hJQSZ
PQoeYqPfWShUatbS/Q0kpwYdoGI0GJ2cDFN36/ET8wDgTuMwj1OHJIRN0aeZ3CmGsBEyrP8G6zEB
BKiQnYTooqpaaIkdDKElbrSKSXxZQ37Uba+vmSNky4eSJ9WAMw5h7DgQeIvIThYAXIxtaTBrpCSO
VWBfkyxSLdYYSMnLA5Glj3FZQzYHePQW9rxFA3iAT9iE9iLDYAxYzCFIkoQyBsM77mHC5hesDWGC
AMAm+mB7i+pC82F7e4HH6kHFf13idM08mnfvi1/H7CB0b3HgawaQ0b86B735LbCBD4zgBB8nwOPZ
wQT+qeAbKnjCFKaJeCrs3fEq4APe9YAECHzgC5MExBgu8W9sJuLbfI8f/D1uryRQgRxg1BjD04C5
ntIP/5j4Ninmxxp3DGTZ1JCqvCExPwD/eZEHG5nIluAVaav2HKsomRzCPcQ/8vLkwxBXsheRh0JM
40JUgABMD84J/8aHCtE88sdBbnNrhhweO+nFAAoQMAEIkADmxZMkWb6Fh3NRVCN6wwYZwOMKfHCA
J7dAAXtk3mAaBlceIECxlsCW2IiMpMCuSSYPkexj6mEEGhwabkAgUKsu0dNBfLiCO0AffwDyGK45
BVtoFHTK3Izr1yxQHdGqxiEwoNiw8XeNfjLAorlbCB7wIAk4/ubmfOJEt+VOURpgMiGQvb6nDIoH
vp4KJcRJCGaY9RAxNnY2lMjstwoRPQ98SNj6MYBUo0LGi37JssnRUHV4ENSCjq8ljN2I/w8PZtna
Tkd/uE3Uqg5CTO9WyHm6m+uIH6ZWvI7sUeVJDoXdYh/jMMyiFVBmkHAGBScIVcXlWgBsGMAFYuKF
AEnzlmGSvFZWtjgqEqbbj6mygErWAS9mLrQtZ2BLh0BtB1sI4jRqgAc7IHnebAWQRtYjtVIUhewA
y8cNOpqMAKiEyWJkPW19GYwSL/thEEgU8mI9HoEehGEcUqICKmDV4kAB0CUVrVTIGgCNzYpX6kiS
fdg4EyVHl25vsUc1FxMVewTshwkgjdBGy9MnUHvRbSLqQ6CsHpYHQBZPZEmApKfH4Zbhd6bbiLm3
5Oe7nAlfAiDM8tHgUYTYPDLNjvu3QP9838HMmYduURmgHqg8MfpOEkqXjlpSpH/c4HAUi/ilt3D0
3kDQQUMxjopUiUYdnScEvQtYgekPwvaHp0ggCYETnYfFcfKdidEIwQqLCegAobiUgN2eTl6kRx3A
JAbzJwAUTQML8xdvmZV7B0gTmqEW4kFE6EdaJ7ACo6AAIBAqckcuhEByJ6AB7AE+E7AkhqF9JwFL
UFYPFzgIKEBWd0F0D2F0ZERiH9cI39F0KsJbnXQIPaYwONF2jCB3vmMZXQI3YBJRkBQjlxI6HkdO
CbSBnEY80VcqMtVFCsMMtyUvLYaAV2hw/fEZvfc5hPAeFgBzt7BZAFADtqMALZBFAUH/c4MgenRR
ABUwAYZRNz7wNYlWaocwXdGgAU03HZZ0CEdQebCXZu5xGGnYh6ejWKT3hXi0SprWQWeIgYVnF3mH
G4HlaExITADQfaHxhclhZFgIionzfoMQfwYVON3gK5tYEpwDbMPTNDUTb2pnTUfGbDVzIa0wVyXW
OuVBEhBjfcEhIsfXGrHIZqFojMeIjIiRh0HWQsWYjM8IjdF4CzsojdVojdfYZjaFjdvIjd3ojd8I
juEojuNIjuVojueIjumojuvIju3oju8Ij/Eoj/NIj/Voj/eIj/moj/vIj/3oj/8IkAEpkANJkAVp
kAeJkAmpkAvJkA3pkA8JkREpkRNJGJEVaZEXiZEZqZEbyZEd6ZEfCZIhyY2BAAA7

------=_NextPart_000_0005_01C7B5DF.40E7B550--


